Your best medicine news resource
Dec 19th 2008Drug InformationLiver Disease / Hepatitis
The following highlights efforts that seek to reduce racial and ethnic health disparities.
More: continued here
Dec 11th 2008Drug InformationLiver Disease / Hepatitis
Human Genome Sciences, Inc. (Nasdaq: HGSI) announced that Albuferon(R) (albinterferon alfa-2b) met its primary endpoint of non-inferiority to peginterferon alfa-2a (Pegasys) in ACHIEVE 2/3, a Phase 3 clinical trial of Albuferon in combination with ribavirin in treatment-naive patients with genotypes 2 and 3 chronic hepatitis C (p=0.0086).
More: continued here
Dec 11th 2008Drug InformationLiver Disease / Hepatitis
Today, Bristol-Myers Squibb Company (NYSE: BMY) announced the launch of its first-ever, non-English-language television campaign in the United States. The campaign, exclusively in Mandarin, seeks to raise awareness of chronic hepatitis B and encourages people to talk with their doctors about managing the disease - one that is disproportionately affecting the Chinese community.
More: continued here
Your best medicine news resource
